HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck Cancer

Clinical trial NCT01984359 · COMPLETED

Trial details

NCT number: NCT01984359
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Subjects With p16 Positive/HPV Positive Squamous Cell Carcinomas of the Oropharynx

Start date: 2013-05-01
Primary completion: 2015-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.